NCT03795792View on ClinicalTrials.gov

Oral Curcumin Administration to Remit Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 6, 2018

Primary Completion Date

August 6, 2019

Study Completion Date

December 6, 2019

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Curcumin

Will be provided in capsules

DIETARY_SUPPLEMENT

Hydrolyzed collagen

Will be provided in capsules.

Trial Locations (1)

34067

Biomedical Research Unit. IMSS. Durango, Durango

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT03795792 - Oral Curcumin Administration to Remit Metabolic Syndrome | Biotech Hunter | Biotech Hunter